Horizon Pharma, Inc. (HZNP)
-NasdaqGM 2.39 
0.01(0.42%) May 22, 4:00PM EDT|After Hours
:
2.39 0.00 (0.00%) May 22, 4:31PM EDT
| Prev Close: | 2.38 |
|---|
| Open: | 2.37 |
|---|
| Bid: | 1.94 x 100 |
|---|
| Ask: | 3.18 x 1000 |
|---|
| 1y Target Est: | 5.33 |
|---|
| Beta: | 2.539 |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 2.35 - 2.44 |
|---|
| 52wk Range: | 1.97 - 8.72 |
|---|
| Volume: | 237,180 |
|---|
| Avg Vol (3m): | 508,239 |
|---|
| Market Cap: | 150.08M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -1.78 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- HORIZON PHARMA, INC. FinancialsEDGAR Online Financials(Fri, May 17)
- Horizon Pharma CEO Discuses Q1 2013 Results - Earnings Call Transcriptat Seeking Alpha(Fri, May 10)
- Horizon Pharma Announces First Quarter 2013 Financial Results and Provides Business UpdateMarketwired(Fri, May 10)
- HORIZON PHARMA, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and ExhiEDGAR Online(Thu, May 9)
- Horizon Pharma Earnings Preview: Get Ahead of the Analystsat Wall St. Cheat Sheet(Thu, May 9)
- Horizon Pharma to Host Conference Call and Webcast to Discuss First Quarter 2013 Financial Results on May 10, 2013Marketwired(Mon, Apr 29)
- Ask a Fool: Buffett's Biggest Misconceptionat Motley Fool(Fri, Apr 12)
- Horizon Pharma to Present at the 20th Annual Future Leaders in the Biotech Industry ConferenceMarketwired(Thu, Mar 28)
- Whoa! These 3 Stocks Just Beat the Dowat Motley Fool(Tue, Mar 26)
- 3 Stocks That Blew the Market Awayat Motley Fool(Mon, Mar 25)
- Has Horizon Pharma's Share Price Bottomed Out?at Seeking Alpha(Sun, Mar 24)
- Horizon Pharma's CEO Discusses Q4 2012 Results - Earnings Call Transcriptat Seeking Alpha(Mon, Mar 18)
- Q4 2012 Horizon Pharma Inc Earnings Release - Before Market OpenCCBN(Mon, Mar 18)
- Horizon Pharma Reports 2012 Financial Results and Provides Business UpdateMarketwired(Mon, Mar 18)
- HORIZON PHARMA, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and ExhiEDGAR Online(Sun, Mar 17)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 5.69 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | -1.24 |
|---|
| Quarterly EPS Est
(Jun-13)
: | -0.35 |
|---|
| Mean Recommendation*: | 1.8 |
|---|
| PEG Ratio (5 yr expected): | -0.10 |
|---|
Business Summary
Horizon Pharma, Inc., a specialty pharmaceutical company, through its subsidiaries, develops and commercializes medicines for the treatment of arthritis, pain, and inflammatory diseases.
View More